Potential role of zinc supplementation in prophylaxis and treatment of COVID-19

Abstract Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the largest current health challenge for the society. At the moment, the therapeutic strategies to deal with this disease are only supportive. It is well known that zinc (Zn) possesses a variety of direct and indirect antiviral properties, which are realized through different mechanisms. Administration of Zn supplement has a potential to enhance antiviral immunity, both innate and humoral, and to restore depleted immune cell function or to improve normal immune cell function, in particular in immunocompromised or elderly patients. Zn may also act in a synergistic manner when co-administered with the standard antiviral therapy, as was demonstrated in patients with hepatitis C, HIV, and SARS-CoV-1. Effectiveness of Zn against a number of viral species is mainly realized through the physical processes, such as virus attachment, infection, and uncoating. Zn may also protect or stabilize the cell membrane which could contribute to blocking of the virus entry into the cell. On the other hand, it was demonstrated that Zn may inhibit viral replication by alteration of the proteolytic processing of replicase polyproteins and RNA-dependent RNA polymerase (RdRp) in rhinoviruses, HCV, and influenza virus, and diminish the RNA-synthesizing activity of nidoviruses, for which SARS-CoV-2 belongs. Therefore, it may be hypothesized that Zn supplementation may be of potential benefit for prophylaxis and treatment of COVID-19.

[1]  P. Bornstein,et al.  Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn. , 1981, The Journal of biological chemistry.

[2]  W. Melchers,et al.  PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells. , 2007, The Journal of general virology.

[3]  M. Kielian,et al.  Identification of a Specific Region in the E1 Fusion Protein Involved in Zinc Inhibition of Semliki Forest Virus Fusion , 2012, Journal of Virology.

[4]  Z. Hong,et al.  Characterization of Soluble Hepatitis C Virus RNA-Dependent RNA Polymerase Expressed in Escherichia coli , 1999, Journal of Virology.

[5]  L. Rink,et al.  Zinc-altered immune function. , 2003, The Journal of nutrition.

[6]  J. C. Godfrey,et al.  How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action. , 1996, Medical hypotheses.

[7]  S. Perlman,et al.  Intracellular processing of the N-terminal ORF 1a proteins of the coronavirus MHV-A59 requires multiple proteolytic events , 1992, Virology.

[8]  Andreas Grassauer,et al.  Antiviral Effects of Pyrrolidine Dithiocarbamate on Human Rhinoviruses , 2002, Journal of Virology.

[9]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[10]  L. Rink,et al.  Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases , 2008, Archivum Immunologiae et Therapiae Experimentalis.

[11]  L. Rink,et al.  Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[12]  R. Baric,et al.  Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture , 2010, PLoS pathogens.

[13]  V. De Maertelaer,et al.  Systemic treatments for cutaneous warts: A systematic review , 2012, The Journal of dermatological treatment.

[14]  J. C. Godfrey,et al.  Zinc-induced suppression of inflammation in the respiratory tract, caused by infection with human rhinovirus and other irritants. , 1997, Medical hypotheses.

[15]  J. Ziebuhr,et al.  Nidovirales: Evolving the largest RNA virus genome , 2006, Virus Research.

[16]  A. M. Leontovich,et al.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.

[17]  T. Masaki,et al.  Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease , 2018, Nutrients.

[18]  Y. Hannun,et al.  Zinc Is a Potent Inhibitor of the Apoptotic Protease, Caspase-3 , 1997, The Journal of Biological Chemistry.

[19]  S. Sungkanuparph,et al.  Low plasma zinc levels and immunological responses to zinc supplementation in HIV-infected patients with immunological discordance after antiretroviral therapy. , 2013, Japanese journal of infectious diseases.

[20]  T. Varadinova,et al.  Complexes of Zinc With Picolinic and Aspartic Acids Inactivate Free Varicella-Zoster Virions , 1996, Metal-based drugs.

[21]  Keun Ho Lee,et al.  Zinc induces apoptosis on cervical carcinoma cells by p53-dependent and -independent pathway. , 2017, Biochemical and biophysical research communications.

[22]  C. Pasternak.  A novel form of host defence: Membrane protection by Ca2+ and Zn2+ , 1987, Bioscience reports.

[23]  J. Hadden,et al.  Zinc induces thymulin secretion from human thymic epithelial cells in vitro and augments splenocyte and thymocyte responses in vivo. , 1995, International journal of immunopharmacology.

[24]  Christopher T. Jones,et al.  A diverse array of gene products are effectors of the type I interferon antiviral response , 2011, Nature.

[25]  R. Martorell,et al.  Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. , 2000, The American journal of clinical nutrition.

[26]  C. Gibbs,et al.  Biochemical characterization of rhinovirus RNA-dependent RNA polymerase. , 2002, Antiviral research.

[27]  S. Perlman,et al.  Coronaviruses post-SARS: update on replication and pathogenesis , 2009, Nature Reviews Microbiology.